دورية أكاديمية

Infant lung function and early skin barrier impairment in the development of asthma at age 3 years.

التفاصيل البيبلوغرافية
العنوان: Infant lung function and early skin barrier impairment in the development of asthma at age 3 years.
المؤلفون: Färdig M; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden., Hoyer A; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden., Almqvist C; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Bains KES; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway., Carlsen KCL; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway., Gudmundsdóttir HK; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway., Granum B; Department of Chemical Toxicology, Norwegian Institute of Public Health, Oslo, Norway., Haugen GN; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Division of Obstetrics and Gynaecology, Oslo University Hospital, Oslo, Norway., Hedlin G; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden., Jonassen CM; Department of Virology, Norwegian Institute of Public Health, Oslo, Norway.; Genetic Unit, Centre for Laboratory Medicine, Østfold Hospital Trust, Kalnes, Norway., Konradsen JR; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden., Lie A; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway., Rehbinder EM; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Dermatology and Vaenerology, Oslo University Hospital, Oslo, Norway., Skjerven HO; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway., Staff AC; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Division of Obstetrics and Gynaecology, Oslo University Hospital, Oslo, Norway., Vettukattil R; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway., Söderhäll C; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden., Nordlund B; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
المصدر: Allergy [Allergy] 2024 Mar; Vol. 79 (3), pp. 667-678. Date of Electronic Publication: 2024 Jan 18.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 7804028 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1398-9995 (Electronic) Linking ISSN: 01054538 NLM ISO Abbreviation: Allergy Subsets: MEDLINE
أسماء مطبوعة: Publication: Copenhagen : Wiley-Blackwell
Original Publication: Copenhagen, Munksgaard.
مواضيع طبية MeSH: Eczema*/epidemiology , Eczema*/genetics , Asthma*/epidemiology , Asthma*/genetics , Asthma*/complications , Dermatitis, Atopic*/diagnosis, Child ; Infant ; Male ; Female ; Humans ; Child, Preschool ; Genotype ; Mutation ; Lung ; Intermediate Filament Proteins/genetics
مستخلص: Background: Largely unexplored, we investigated if lower lung function, impaired skin barrier function by transepidermal water loss (TEWL), eczema, and filaggrin (FLG) mutations in infancy were associated with asthma in early childhood.
Methods: From the factorially designed randomized controlled intervention study PreventADALL, we evaluated 1337/2394 children from all randomization groups with information on asthma at age 3 years, and at age 3 months either lung function, TEWL, eczema, and/or FLG mutations. Lower lung function was defined as the time to peak tidal expiratory flow to expiratory time (t PTEF /t E ) <0.25, and skin barrier impairment as a high TEWL >9.50 g/m 2 /h. Eczema was clinically observed, and DNA genotyped for FLG mutations. Asthma was defined as asthma-like symptoms (≥3 episodes of bronchial obstruction) between age 2-3 years as well as a history of doctor-diagnosed asthma and/or asthma medication use. Associations were analyzed in logistic regression models, presented with adjusted ORs (aOR) and 95% confidence intervals (CI).
Results: Lower lung function and skin barrier impairment were associated with asthma in general; aOR (95% CI) 5.4 (2.1, 13.7) and 1.6 (1.1, 2.5), while eczema and FLG mutations were associated with asthma in children with atopic dermatitis or allergic sensitization only. Stratifying for sex, the risk of asthma was only increased in boys with lower lung function; aOR (95% CI) 7.7 (2.5, 23.6), and in girls with FLG mutations; aOR (95% CI) 3.5 (1.5, 8.2).
Conclusion: Lower lung function and impaired skin barrier function in infancy may increase the risk of asthma at age 3 years.
(© 2024 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.)
References: Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. Lancet. 2018;391(10122):783-800.
von Mutius E. Trajectories of childhood wheeze. J Allergy Clin Immunol. 2011;127(6):1513-1514.
Martinez FD. What have we learned from the Tucson Children's respiratory study? Paediatr Respir Rev. 2002;3(3):193-197.
Dai R, Miliku K, Gaddipati S, et al. Wheeze trajectories: determinants and outcomes in the CHILD cohort study. J Allergy Clin Immunol. 2022;149(6):2153-2165.
Kaiser SV, Huynh T, Bacharier LB, et al. Preventing exacerbations in preschoolers with recurrent wheeze: a meta-analysis. Pediatrics. 2016;137(6).
Fitzpatrick AM, Grunwell JR, Cottrill KA, Mutic AD, Mauger DT. Blood eosinophils for prediction of exacerbation in preschool children with recurrent wheezing. J Allergy Clin Immunol Pract. 2023;11(5):1485-1493 e8.
Yaneva M, Darlenski R. The link between atopic dermatitis and asthma-immunological imbalance and beyond. Asthma Res Pract. 2021;7(1):16.
Akdis CA. Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions? Nat Rev Immunol. 2021;21(11):739-751.
Elias PM. Stratum corneum defensive functions: an integrated view. J Invest Dermatol. 2005;125(2):183-200.
Knight DA, Holgate ST. The airway epithelium: structural and functional properties in health and disease. Respirology. 2003;8(4):432-446.
Wärnberg Gerdin S, Lie A, Asarnoj A, et al. Impaired skin barrier and allergic sensitization in early infancy. Allergy. 2022;77(5):1464-1476.
Yang L, Fu J, Zhou Y. Research progress in atopic march. Front Immunol. 2020;11:1907.
Kubo A, Nagao K, Amagai M. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J Clin Invest. 2012;122(2):440-447.
Kim BE, Leung DYM. Significance of skin barrier dysfunction in atopic dermatitis. Allergy Asthma Immunol Res. 2018;10(3):207-215.
Horimukai K, Morita K, Narita M, et al. Transepidermal water loss measurement during infancy can predict the subsequent development of atopic dermatitis regardless of filaggrin mutations. Allergol Int. 2016;65(1):103-108.
Hoyer A, Rehbinder EM, Färdig M, et al. Filaggrin mutations in relation to skin barrier and atopic dermatitis in early infancy. Br J Dermatol. 2022;186(3):544-552.
Tenn MW, Ellis AK. The clinical relevance of filaggrin mutations: effect on allergic disease. Ann Allergy Asthma Immunol. 2016;117(5):483-489.
Färdig M, Gudmundsdóttir HK, Hoyer A, et al. Skin barrier function and infant tidal flow-volume loops-a population-based observational study. Children. 2022;10(1).
Haland G, Carlsen KC, Sandvik L, et al. Reduced lung function at birth and the risk of asthma at 10 years of age. N Engl J Med. 2006;355(16):1682-1689.
Lødrup Carlsen KC, Mowinckel P, Hovland V, Håland G, Riiser A, Carlsen KH. Lung function trajectories from birth through puberty reflect asthma phenotypes with allergic comorbidity. J Allergy Clin Immunol. 2014;134(4):917-923.e7.
Stocks J, Dezateux CA, Jackson EA, Hoo AF, Costeloe KL, Wade AM. Analysis of tidal breathing parameters in infancy: how variable is tPTEF:tE? Am J Respir Crit Care Med. 1994;150(5 Pt 1):1347-1354.
Anık A, Uysal P. Impaired lung functions using tidal breath analysis in high-risk infants with recurrent wheezing. Tip. 2020;1(2):49-54.
Beydon N, Davis SD, Lombardi E, et al. An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med. 2007;175(12):1304-1345.
Çelik E, Uysal P. Pulmonary function testing with tidal breath analyze technique is useful in predicting persistant small airway damage in infants with acute bronchiolitis. Pediatr Allergy Immunol. 2021;32(1):60-66.
Lodrup Carlsen KC, Rehbinder EM, Skjerven HO, et al. Preventing atopic dermatitis and ALLergies in children-the PreventADALL study. Allergy. 2018;73(10):2063-2070.
Skjerven HO, Rehbinder EM, Vettukattil R, et al. Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial. Lancet. 2020;395(10228):951-961.
Bains KES, Gudmundsdóttir HK, Färdig M, et al. Infant lung function: criteria for selecting tidal flow-volume loops. ERJ Open Res. 2022;8(4):00165-2022.
Lodrup Carlsen KC, Carlsen KH, Nafstad P, Bakketeig L. Perinatal risk factors for recurrent wheeze in early life. Pediatr Allergy Immunol. 1999;10(2):89-95.
Hevroni A, Goldman A, Blank-Brachfeld M, Abu Ahmad W, Ben-Dov L, Springer C. Use of tidal breathing curves for evaluating expiratory airway obstruction in infants. J Asthma. 2018;55(12):1331-1337.
Morris MJ, Lane DJ. Tidal expiratory flow patterns in airflow obstruction. Thorax. 1981;36(2):135-142.
Rehbinder EM, Advocaat Endre KM, Lødrup Carlsen KC, et al. Predicting skin barrier dysfunction and atopic dermatitis in early infancy. J Allergy Clin Immunol Pract. 2020;8(2):664-673.
Brenninkmeijer EE, Schram ME, Leeflang MM, Bos JD, Spuls PI. Diagnostic criteria for atopic dermatitis: a systematic review. Br J Dermatol. 2008;158(4):754-765.
Lie A, Wärnberg Gerdin S, Skrindo I, et al. Evaluation of skin prick test reading time at 10 versus 15 min in young infants. Int Arch Allergy Immunol. 2022;183(8):824-834.
Lødrup Carlsen KC, Roll S, Carlsen KH, et al. Does pet ownership in infancy lead to asthma or allergy at school age? Pooled analysis of individual participant data from 11 European birth cohorts. PLoS One. 2012;7(8):e43214.
Rehbinder EM, Advocaat Endre KM, Lodrup Carlsen KC, et al. Predicting skin barrier dysfunction and atopic dermatitis in early infancy. J Allergy Clin Immunol Pract. 2020;8(2):664-673 e5.
Just J, Bourgoin-Heck M, Amat F. Clinical phenotypes in asthma during childhood. Clin Exp Allergy. 2017;47(7):848-855.
den Dekker HT, Sonnenschein-van der Voort AM, de Jongste JC, et al. Early growth characteristics and the risk of reduced lung function and asthma: a meta-analysis of 25,000 children. J Allergy Clin Immunol. 2016;137(4):1026-1035.
Magnusson LL, Olesen AB, Wennborg H, Olsen J. Wheezing, asthma, hayfever, and atopic eczema in childhood following exposure to tobacco smoke in fetal life. Clin Exp Allergy. 2005;35(12):1550-1556.
Sbihi H, Tamburic L, Koehoorn M, Brauer M. Perinatal air pollution exposure and development of asthma from birth to age 10 years. Eur Respir J. 2016;47(4):1062-1071.
To T, Zhu J, Stieb D, et al. Early life exposure to air pollution and incidence of childhood asthma, allergic rhinitis and eczema. Eur Respir J. 2020;55(2):1900913.
Miliku K, Azad MB. Breastfeeding and the developmental origins of asthma: current evidence, possible mechanisms, and future research priorities. Nutrients. 2018;10(8).
Peters RL, Kay T, McWilliam VL, et al. The interplay between eczema and breastfeeding practices may Hide Breastfeeding's protective effect on childhood asthma. J Allergy Clin Immunol Pract. 2021;9(2):862-871.e5.
Jaakkola JJ, Hwang BF, Jaakkola N. Home dampness and molds, parental atopy, and asthma in childhood: a six-year population-based cohort study. Environ Health Perspect. 2005;113(3):357-361.
Pinart M, Albang R, Maier D, et al. Systematic review on the definition of allergic diseases in children: the MeDALL study. Int Arch Allergy Immunol. 2015;168(2):110-121.
Hammer-Helmich L, Linneberg A, Thomsen SF, Glümer C. Association between parental socioeconomic position and prevalence of asthma, atopic eczema and hay fever in children. Scand J Public Health. 2014;42(2):120-127.
Localio AR, Berlin JA, Ten Have TR, Kimmel SE. Adjustments for center in multicenter studies: an overview. Ann Intern Med. 2001;135(2):112-123.
Dvornyk V, Ponomarenko I, Belyaeva T, Reshetnikov E, Churnosov M. Filaggrin gene polymorphisms are associated with atopic dermatitis in women but not in men in the Caucasian population of Central Russia. PLoS One. 2021;16(12):e0261026.
Guerra S, Lombardi E, Stern DA, et al. Fetal origins of asthma: a longitudinal study from birth to age 36 years. Am J Respir Crit Care Med. 2020;202(12):1646-1655.
Löffler H, Effendy I. Skin susceptibility of atopic individuals. Contact Dermatitis. 1999;40(5):239-242.
Izquierdo E, Rodriguez-Coira J, Delgado-Dolset MI, Gomez-Casado C, Barber D, Escribese MM. Epithelial barrier: protector and trigger of allergic disorders. J Investig Allergol Clin Immunol. 2022;32(2):81-96.
Müller S, Marenholz I, Lee YA, et al. Association of Filaggrin loss-of-function-mutations with atopic dermatitis and asthma in the early treatment of the atopic child (ETAC) population. Pediatr Allergy Immunol. 2009;20(4):358-361.
Sugiura S, Hiramitsu Y, Futamura M, et al. Clinical risk factors at 3 months of age for the development of bronchial asthma at 36 months of age. Pediatr Int. 2023;65:e15530.
Ziyab AH, Karmaus W, Zhang H, et al. Association of filaggrin variants with asthma and rhinitis: is eczema or allergic sensitization status an effect modifier? Int Arch Allergy Immunol. 2014;164(4):308-318.
von Kobyletzki LB, Bornehag CG, Hasselgren M, Larsson M, Lindström CB, Svensson Å. Eczema in early childhood is strongly associated with the development of asthma and rhinitis in a prospective cohort. BMC Dermatol. 2012;12:11.
Endre KMA, Landrø L, LeBlanc M, et al. Diagnosing atopic dermatitis in infancy using established diagnostic criteria: a cohort study. Br J Dermatol. 2022;186(1):50-58.
Lowe AJ, Carlin JB, Bennett CM, et al. Do boys do the atopic march while girls dawdle? J Allergy Clin Immunol. 2008;121(5):1190-1195.
Skjerven HO, Lie A, Vettukattil R, et al. Early food intervention and skin emollients to prevent food allergy in young children (PreventADALL): a factorial, multicentre, cluster-randomised trial. Lancet. 2022;399(10344):2398-2411.
Thyssen JP, Bikle DD, Elias PM. Evidence that loss-of-function Filaggrin gene mutations evolved in northern Europeans to favor Intracutaneous vitamin D3 production. Evol Biol. 2014;41(3):388-396.
Gustafsson D, Sjöberg O, Foucard T. Development of allergies and asthma in infants and young children with atopic dermatitis-a prospective follow-up to 7 years of age. Allergy. 2000 Mar;55(3):240-245.
معلومات مُعتمدة: The Norwegian Research Council; South-Eastern Norway Regional Health Authority; The University of Oslo; Oslo University Hospital; The Foundation for Healthcare and Allergy Research in Sweden -Vårdalstiftelsen; Health and Rehabilitation Norway; Fürst Medical Laboratory, Oslo, Norway; Thermo Fisher Scientific, Uppsala, Sweden; Arne Ingel's legat; Norwegian Society of Dermatology and Venerology; Forskningsrådet om Hälsa, Arbetsliv och Välfärd; Region Stockholm; The Sven Jerring Foundation; Swedish Order of Freemasons Foundation Barnhuset; The Swedish Research Council - the Initiative for Clinical Therapy Research; SFO-V Karolinska Institutet; The Swedish Heart-Lung Foundation; Sykehuset Østfold; The Kloster foundation; The Norwegian Association of Asthma and Allergy; Barnestiftelsen at Oslo University Hospital; The Samaritan Foundation for Pediatric Research; The Frithjof Nansen Institute; Roche; The Magnus Bergwall foundation; The Hesselman Foundation; The Swedish Society of Medicine; The Konsul Th C Bergh's Foundation; KI grants; The King Gustaf V 80th Birthday Foundation; The Pediatric Research Foundation at Astrid Lindgren Children's Hospital; The Cancer- and Allergy Foundation; The Swedish Asthma and Allergy Association's Research Foundation
فهرسة مساهمة: Keywords: PreventADALL; asthma; infants; lung function; skin barrier function
المشرفين على المادة: 0 (Intermediate Filament Proteins)
تواريخ الأحداث: Date Created: 20240119 Date Completed: 20240301 Latest Revision: 20240710
رمز التحديث: 20240710
DOI: 10.1111/all.16024
PMID: 38239099
قاعدة البيانات: MEDLINE
الوصف
تدمد:1398-9995
DOI:10.1111/all.16024